Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.12p
   
  • Change Today:
      0.25p
  • 52 Week High: 6.25
  • 52 Week Low: 0.88
  • Currency: UK Pounds
  • Shares Issued: 4,766.44m
  • Volume: 2,801,938
  • Market Cap: £148.71m
  • RiskGrade: 268

Cash Flow

  £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Cash Flow Statement 30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
         
Net Cash Flow From Operating Activities (2.03) 1.70 (0.44) (19.32)
ROI, Servicing of Finance        
Assocs/JV Dividends Received bn/a bn/a bn/a bn/a
Interests & Other Dividends Received n/a n/a n/a n/a
Interest Paid bn/a bn/a bn/a bn/a
Minorities & Non-Equity Divs Paid bn/a bn/a bn/a bn/a
  n/a n/a n/a n/a
         
Taxation Paid bn/a bn/a bn/a bn/a
         
Gross Cash Flow bn/a bn/a bn/a bn/a
         
Capital Expd & Financial Inv        
Interests & Other Dividends Received n/a 0.01 0.03 0.20
Disposal of Property, Plant & Equipment n/a n/a n/a n/a
Disposal of Investments n/a n/a n/a n/a
Purchase of Property, Plant & Equipment (1.15) (1.64) (1.43) (2.47)
Purchase of Investments (1.05) (0.32) (0.30) (0.26)
Net Purchase of Intangible Assets (0.09) (0.06) (0.29) (0.15)
Other Investing Cash Flow n/a n/a n/a n/a
  (2.29) (2.01) (1.99) (2.68)
Financing Activities        
Dividends Paid n/a n/a n/a n/a
Repayments of Borrowings (8.26) (43.29) (2.25) (1.84)
Borrowings 9.02 22.44 2.26 20.41
Other Financing Cash Flow n/a 25.74 0.09 0.04
  0.76 4.89 0.10 18.60
Net Increase/Decrease In Cash (3.55) 4.59 (2.32) (3.40)


Key Financials 30-Jun-11 30-Jun-10 30-Jun-09 30-Jun-08
         
Shares in Issue - Year End 310.77 310.76 82.37 81.95
         
Financial Data        
Cash Incr/Decr per Share (1.14p) 1.56p (2.83p) (4.15p)
Operating Cash Flow per Share (0.65p) 0.58p (0.54p) (23.58p)
Gross Cash Flow per Share bn/a bn/a bn/a bn/a
         
Market Data        
Price/Operating Cash Flow (21.5) 19.8 (26.1) (1.2)

Key

* GAAP

a. Operating activities before tax

b. Not disclosed under IFRS

c. Not previously included in financing activities

d. Based on operating cash flow before tax

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page